Infection worries prompt EU review of Gilead leukemia drug
 

Infection worries prompt EU review of Gilead leukemia drug
LONDON (Reuters) - European regulators have started a review into the safety of Gilead Sciences' leukemia drug Zydelig due to concerns over serious adverse events, including deaths.


http://rc.feedsportal.com/r/24739447...13/rc/1/rc.img

http://rc.feedsportal.com/r/24739447...13/rc/2/rc.img

http://rc.feedsportal.com/r/24739447...13/rc/3/rc.img

http://da.feedsportal.com/r/24739447...9/sc/13/a2.img
http://adchoice.feedsportal.com/r/24.../sc/13/ach.imghttp://pi.feedsportal.com/r/24739447.../sc/13/a2t.imghttp://pi2.feedsportal.com/r/2473944...sc/13/a2t2.imghttp://i1.wp.com/reuters.us.feedspor...f?resize=1%2C1http://feeds.feedburner.com/~ff/reut...?d=yIl2AUoC8zA http://feeds.feedburner.com/~ff/reut...dw:F7zBnMyn0Lo http://feeds.feedburner.com/~ff/reut...dw:V_sGLiPBpWU
http://feeds.feedburner.com/~r/reute...~4/vXC3ghKwNps